Economic benefits with high-dose IIV3 in elderly US patients

November 2016, Volume 765, Issue 1, pp 15–15 | Cite as

Clinical study

First Online: 05 November 2016

This is a preview of subscription content, to check access.

Reference

Raviotta JM, et al. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults. Journal of the American Geriatrics Society : 6 Oct 2016. Available from: URL: http://dx.doi.org/10.1111/jgs.14323

Cite this article as:: PharmacoEcon Outcomes News (2016) 765: 15. https://doi.org/10.1007/s40274-016-3500-8

Get Access to

PharmacoEconomics & Outcomes News

for the whole of 2018